Spontaneous sustained monomorphic ventricular tachycardia after administration of ajmaline in a patient with Brugada syndrome

Pacing Clin Electrophysiol. 2000 Mar;23(3):407-9. doi: 10.1111/j.1540-8159.2000.tb06771.x.

Abstract

We present the case of a 13-year-old boy with an episode of aborted sudden death, absence of structural heart disease, and a characteristic ECG pattern of right bundle branch block with persistent ST-segment elevation in the right precordial leads, in whom a monomorphic sustained ventricular tachycardia developed spontaneously after the administration of ajmaline. This effect may be related to an increased inhomogeneity of repolarization mediated by the drug and demonstrates the arrhythmogenic potential of Class I antiarrhythmic drugs in patients with Brugada syndrome.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Ajmaline / adverse effects*
  • Anti-Arrhythmia Agents / adverse effects*
  • Bundle-Branch Block / drug therapy*
  • Electrocardiography
  • Humans
  • Male
  • Syndrome
  • Tachycardia, Ventricular / chemically induced*
  • Tachycardia, Ventricular / physiopathology
  • Ventricular Fibrillation / drug therapy*

Substances

  • Anti-Arrhythmia Agents
  • Ajmaline